Aurobindo Pharma USA, Inc. v. Andrx Corporation
| ANDRX LABORATORIES, INC., ANDRX LABORATORIES (NJ) INC., ANDRX CORPORATION, ANDRX PHARMACEUTICALS, LLC, TEVA PHARMACEUTICAL INDUSTRIES LTD. and ANDRX EU LTD. |
| AUROBINDO PHARMA USA, INC. |
| 19-1620 |
| March 5, 2019 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 15, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 4
ORDER filed. The appeal is dismissed pursuant to Fed. R. App. P. 42(b) [ # 2 ] [ # 3 ]; issuing mandate. Service as of this date by the Clerk of Court. [593088] [MMA] [Entered: 03/15/2019 10:08 AM]
|
| Filing 3 MODIFIED ENTRY: Stipulated Dismissal with Prejudice for Appellant Aurobindo Pharma USA, Inc.. Service: 03/14/2019 by email, US mail. [592947] [19-1620] --[Edited 03/15/2019 by CAB to add correct relief] [Steven Moore] [Entered: 03/14/2019 04:22 PM] |
| Filing 2 MODIFIED ENTRY: Stipulated Dismissal with Prejudice for Appellant Aurobindo Pharma USA, Inc.. Service: 03/13/2019 by email. [592610] [19-1620] --[Edited 03/14/2019 by CAB to select correct filing event and add correct relief] [Steven Moore] [Entered: 03/13/2019 03:00 PM] |
| Filing 1 Appeal docketed. Received: 02/28/2019. [590286] Entry of Appearance due 03/19/2019. Certificate of Interest is due on 03/19/2019. Docketing Statement due 03/19/2019. Certified List due on 04/15/2019. [MMA] [Entered: 03/05/2019 09:24 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
